KIF21A
Basic information
Region (hg38): 12:39293228-39443390
Previous symbols: [ "FEOM1" ]
Links
Phenotypes
GenCC
Source:
- congenital fibrosis of extraocular muscles type 1 (Strong), mode of inheritance: AD
- congenital fibrosis of extraocular muscles type 1 (Strong), mode of inheritance: AD
- congenital fibrosis of extraocular muscles (Supportive), mode of inheritance: AD
- congenital fibrosis of extraocular muscles type 1 (Definitive), mode of inheritance: AD
- congenital fibrosis of extraocular muscles type 1 (Strong), mode of inheritance: AD
- congenital fibrosis of extraocular muscles (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Fibrosis of extraocular muscles, congenital 1 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 10922204; 14595441; 15621877; 15621876; 15223798; 15671279; 15827546; 18332320; 19896199; 20301522; 21042561; 21805025 |
ClinVar
This is a list of variants' phenotypes submitted to
- Congenital fibrosis of extraocular muscles type 1 (3 variants)
- not provided (2 variants)
- Fibrosis of extraocular muscles, congenital, 3b (2 variants)
- KIF21A-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KIF21A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 13 | 16 | 34 | |||
missense | 95 | 18 | 10 | 128 | ||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 1 | 4 | 4 | 9 | ||
non coding | 26 | 22 | 50 | |||
Total | 3 | 4 | 134 | 34 | 48 |
Variants in KIF21A
This is a list of pathogenic ClinVar variants found in the KIF21A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-39293267-T-A | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 13, 2018) | ||
12-39293402-T-A | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 13, 2018) | ||
12-39293414-A-G | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 12, 2018) | ||
12-39293489-T-C | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 13, 2018) | ||
12-39293578-T-TA | Congenital fibrosis of extraocular muscles | Uncertain significance (Jun 14, 2016) | ||
12-39293612-A-G | Congenital fibrosis of extraocular muscles type 1 | Benign (Jan 13, 2018) | ||
12-39293717-T-C | Congenital fibrosis of extraocular muscles type 1 | Benign (Jan 12, 2018) | ||
12-39293733-GA-G | Congenital fibrosis of extraocular muscles | Benign (Jun 14, 2016) | ||
12-39293733-G-GA | Congenital fibrosis of extraocular muscles | Uncertain significance (Jun 14, 2016) | ||
12-39293734-A-G | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 13, 2018) | ||
12-39293779-A-C | Congenital fibrosis of extraocular muscles type 1 | Benign (Jan 13, 2018) | ||
12-39293842-C-T | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 13, 2018) | ||
12-39293893-A-G | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 12, 2018) | ||
12-39293952-T-C | Congenital fibrosis of extraocular muscles type 1 | Benign (Jan 13, 2018) | ||
12-39293973-T-C | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 13, 2018) | ||
12-39293977-T-C | Congenital fibrosis of extraocular muscles type 1 | Benign (Jan 12, 2018) | ||
12-39294006-T-C | Congenital fibrosis of extraocular muscles type 1 | Benign (Jan 13, 2018) | ||
12-39294058-G-A | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 13, 2018) | ||
12-39294098-A-T | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 12, 2018) | ||
12-39294187-T-C | Congenital fibrosis of extraocular muscles type 1 | Benign (Jan 13, 2018) | ||
12-39294213-G-C | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 12, 2018) | ||
12-39294353-G-C | Congenital fibrosis of extraocular muscles type 1 | Likely benign (Jan 13, 2018) | ||
12-39294359-C-T | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 12, 2018) | ||
12-39294437-A-C | Inborn genetic diseases | Uncertain significance (Mar 28, 2024) | ||
12-39294488-C-A | Congenital fibrosis of extraocular muscles type 1 | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KIF21A | protein_coding | protein_coding | ENST00000361418 | 38 | 150163 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.86e-8 | 1.00 | 125660 | 0 | 88 | 125748 | 0.000350 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.65 | 650 | 870 | 0.747 | 0.0000444 | 11019 |
Missense in Polyphen | 219 | 345.29 | 0.63425 | 4302 | ||
Synonymous | 0.261 | 293 | 299 | 0.981 | 0.0000150 | 3132 |
Loss of Function | 5.88 | 31 | 91.8 | 0.338 | 0.00000497 | 1130 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000326 | 0.000326 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000327 | 0.000326 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000303 | 0.000299 |
Middle Eastern | 0.000327 | 0.000326 |
South Asian | 0.00111 | 0.00108 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Microtubule-binding motor protein probably involved in neuronal axonal transport. In vitro, has a plus-end directed motor activity (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Fibrosis of extraocular muscles, congenital, 1 (CFEOM1) [MIM:135700]: A congenital ocular motility disorder marked by restrictive ophthalmoplegia affecting extraocular muscles innervated by the oculomotor and/or trochlear nerves. It is clinically characterized by anchoring of the eyes in downward gaze, ptosis, and backward tilt of the head. Patients affected by congenital fibrosis of extraocular muscles type 1 show an absence of the superior division of the oculomotor nerve (cranial nerve III) and corresponding oculomotor subnuclei. {ECO:0000269|PubMed:14595441, ECO:0000269|PubMed:16157808, ECO:0000269|PubMed:17511870, ECO:0000269|PubMed:24715754}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Kinesins;Factors involved in megakaryocyte development and platelet production;Hemostasis;COPI-dependent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- loftool
- 0.856
- rvis_EVS
- -0.15
- rvis_percentile_EVS
- 42.34
Haploinsufficiency Scores
- pHI
- 0.209
- hipred
- Y
- hipred_score
- 0.578
- ghis
- 0.546
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.466
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Kif21a
- Phenotype
- cellular phenotype; muscle phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- microtubule-based movement
- Cellular component
- cytosol;kinesin complex;microtubule;plasma membrane
- Molecular function
- microtubule motor activity;protein binding;ATP binding;microtubule binding;ATPase activity